VIEMED HEALTHCARE, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VIEMED HEALTHCARE, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $531.00K, a 60.87% decline year-over-year.
- VIEMED HEALTHCARE, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $526.00K, a 4681.82% increase year-over-year.
- VIEMED HEALTHCARE, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $71.00K, a 21.98% decline year-over-year.
- VIEMED HEALTHCARE, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $1.36M, a 6361.90% increase year-over-year.
- VIEMED HEALTHCARE, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $1.44M, a 41.49% increase from fiscal 2024.
- VIEMED HEALTHCARE, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $1.02M, a 21.95% decline from fiscal 2023.
- VIEMED HEALTHCARE, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $1.30M, a 360.42% increase from fiscal 2022.
- VIEMED HEALTHCARE, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $283.00K, a 152.68% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $531.00K 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $526.00K 10-Q · filed 2026-08-03 | |
| 2025-12-31 | $1.44M 10-K · filed 2026-03-04 | |
| 2025-09-30 | $71.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $1.36M 10-Q · filed 2026-08-03 | |
| 2025-03-31 | $11.00K 10-Q · filed 2026-08-03 | |
| 2024-12-31 | $1.02M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $91.00K 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $21.00K 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $304.00K 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $1.30M 10-K · filed 2026-03-04 | |
| 2023-09-30 | $6.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $684.00K 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $544.00K 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $283.00K 10-K · filed 2025-03-10 | |
| 2022-09-30 | $87.00K 10-Q · filed 2023-11-01 | |
| 2021-12-31 | $112.00K 10-K · filed 2023-03-02 | |
| 2021-06-30 | $47.00K 10-Q · filed 2022-11-01 | |
| 2021-03-31 | $65.00K 10-Q · filed 2022-11-01 | |
| 2020-12-31 | $1.88M 10-K · filed 2022-03-07 | |
| 2020-09-30 | $8.00K 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $1.76M 10-Q · filed 2021-11-02 | |
| 2020-03-31 | $15.00K 10-Q · filed 2021-11-02 | |
| 2019-12-31 | $136.00K 10-K · filed 2021-03-03 | |
| 2019-09-30 | $114.00K 10-Q · filed 2020-11-04 | |
| 2019-06-30 | $18.00K 10-Q · filed 2020-11-04 | |
| 2019-03-31 | $4.00K 10-Q · filed 2020-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |